Deerfield Management Company »

Leidos Holdings shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Leidos Holdings (LDOS) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Leidos Holdings

Tip: Access up to 7 years of quarterly data

All positions including Leidos Holdings held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leidos Holdings by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $453k 4.2k 108.24

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Leidos Holdings

Vanguard Group
Wellington Management Company
Victory Capital Management
Robeco Investment Management
Massachusetts Financial Services
Norges Bank Investment Management
Dimensional Fund Advisors
Jpmorgan Chase & Co
Charles Schwab Investment Management
Bank of New York Mellon
Legal & General Group
Pzena Investment Management
Citadel Advisors
Millennium Management
Man Group

View all funds holding Leidos Holdings